TrialThe lancet. Psychiatry2017

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.

Ian M Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.